A 20-Week Multicenter, Randomized, Double-Blind (DB), Placebo-Controlled, Phase 3 Trial (EPX 100-003) of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in patients with Lennox-Gastaut Syndrome (LGS)

Long-term Tolerability and Efficacy of Adjunctive Brivaracetam in Pediatric Patients with Primary Generalized Seizures: Subgroup Analysis of an Open-label, Follow-up Trial